<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01986686</url>
  </required_header>
  <id_info>
    <org_study_id>RCB1956</org_study_id>
    <nct_id>NCT01986686</nct_id>
  </id_info>
  <brief_title>Recurrence Following Nonoperative Management of 1st Episode of Hinchey II Diverticulitis</brief_title>
  <official_title>Should Elective Resection Follow Nonoperative Management of First Episode of Diverticulitis of the Colon With Abscess and/or Extraluminal Air? A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Stony Brook University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will agree to be randomized to either surgery or observation following nonoperative
      management of a first episode of Hinchey II diverticulitis. Information will be collected on
      recurrence rates and major complications in both groups.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will randomize patients with first episode of acute diverticulitis of the colon
      with extraluminal air and/or abscess as defined by CT scan following nonoperative management
      (NPO, IV antibiotics, percutaneous drainage, and TPN followed by colonoscopy) to observation
      or elective resection. The primary endpoint is recurrent diverticulitis of the colon defined
      as an acute episode confirmed at CT scan and requiring hospitalization with IV antibiotics.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">July 16, 2016</completion_date>
  <primary_completion_date type="Actual">July 16, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Study Endpoint</measure>
    <time_frame>Minimum of 1 year after enrollment</time_frame>
    <description>The primary outcome measure is recurrent diverticulitis of the colon defined as an acute episode confirmed at CT scan and requiring hospitalization with IV antibiotics.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure Length of Hospital Stay for Surgery vs Non Surgery Patients</measure>
    <time_frame>4 years</time_frame>
    <description>Data collected will include length of hospital stay from the date of admission to discharge day for nonoperative management of the first episode of Hinchey II diverticulitis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>4 years</time_frame>
    <description>Data will be collected on percent of patients who die during the follow-up period after enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission</measure>
    <time_frame>30 days</time_frame>
    <description>Data will be collected on percent of patients who are readmitted for recurrence or postoperative complications during the follow-up period after enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post Operative Complications</measure>
    <time_frame>30 days</time_frame>
    <description>Data will be collected on percent and type of complications for the surgery arm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence and Treatment</measure>
    <time_frame>2 years</time_frame>
    <description>Data will be collected on recurrence and treatment for recurrent diverticulitis</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">107</enrollment>
  <condition>Diverticulitis</condition>
  <arm_group>
    <arm_group_label>Observational</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The observation group will be followed clinically with no further intervention until the primary endpoint is reached.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Surgery</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The surgery group will be offered colon resection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Colon resection</intervention_name>
    <description>Elective robotic/laparoscopic/open colon resection for diverticular disease.</description>
    <arm_group_label>Surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  older than or equal to 18

          -  history of resolved first episode of diverticulitis with abscess (Hinchey class II)
             who were successfully treated by our standard protocol

          -  the diagnosis confirmed by colonoscopy

          -  Signed informed consent

        Exclusion Criteria:

          -  Prior episode of diverticulitis

          -  Right sided diverticulitis

          -  Failure of recovery from first episode, defined as recurrence within one month.

          -  Cancer found at the site on screening colonoscopy

          -  Comorbidities prohibiting surgery (as measured by colorectal POSSUM score)

          -  Immunosuppressed patients

          -  Hinchey I, III, or IV (diverticulitis with peritonitis and/or free air under the
             diaphragm)

          -  Patients who are unable to sign the informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roberto C Bergamaschi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stonybrook University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Stony Brook Medicine</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 9, 2013</study_first_submitted>
  <study_first_submitted_qc>November 11, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2013</study_first_posted>
  <results_first_submitted>May 26, 2017</results_first_submitted>
  <results_first_submitted_qc>May 26, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">October 18, 2017</results_first_posted>
  <last_update_submitted>May 26, 2017</last_update_submitted>
  <last_update_submitted_qc>May 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diverticulitis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Observational</title>
          <description>The observation group will be followed clinically with no further intervention until the primary endpoint is reached.</description>
        </group>
        <group group_id="P2">
          <title>Surgery</title>
          <description>The surgery group will be offered colon resection.
Colon resection: Elective robotic/laparoscopic/open colon resection for diverticular disease.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="81"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="81"/>
                <participants group_id="P2" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Observational</title>
          <description>The observation group will be followed clinically with no further intervention until the primary endpoint is reached.</description>
        </group>
        <group group_id="B2">
          <title>Surgery</title>
          <description>The surgery group will be offered colon resection.
Colon resection: Elective robotic/laparoscopic/open colon resection for diverticular disease.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="81"/>
            <count group_id="B2" value="26"/>
            <count group_id="B3" value="107"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="81"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="107"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="55.22" spread="13.05"/>
                    <measurement group_id="B2" value="53.31" spread="13.51"/>
                    <measurement group_id="B3" value="54.61" spread="13.23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="81"/>
                    <count group_id="B2" value="26"/>
                    <count group_id="B3" value="107"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Primary Study Endpoint</title>
        <description>The primary outcome measure is recurrent diverticulitis of the colon defined as an acute episode confirmed at CT scan and requiring hospitalization with IV antibiotics.</description>
        <time_frame>Minimum of 1 year after enrollment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Observational</title>
            <description>The observation group will be followed clinically with no further intervention until the primary endpoint is reached.</description>
          </group>
          <group group_id="O2">
            <title>Surgery</title>
            <description>The surgery group will be offered colon resection.
Colon resection: Elective robotic/laparoscopic/open colon resection for diverticular disease.</description>
          </group>
        </group_list>
        <measure>
          <title>Primary Study Endpoint</title>
          <description>The primary outcome measure is recurrent diverticulitis of the colon defined as an acute episode confirmed at CT scan and requiring hospitalization with IV antibiotics.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="81"/>
                <count group_id="O2" value="26"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Measure Length of Hospital Stay for Surgery vs Non Surgery Patients</title>
        <description>Data collected will include length of hospital stay from the date of admission to discharge day for nonoperative management of the first episode of Hinchey II diverticulitis.</description>
        <time_frame>4 years</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mortality</title>
        <description>Data will be collected on percent of patients who die during the follow-up period after enrollment.</description>
        <time_frame>4 years</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Readmission</title>
        <description>Data will be collected on percent of patients who are readmitted for recurrence or postoperative complications during the follow-up period after enrollment.</description>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post Operative Complications</title>
        <description>Data will be collected on percent and type of complications for the surgery arm.</description>
        <time_frame>30 days</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recurrence and Treatment</title>
        <description>Data will be collected on recurrence and treatment for recurrent diverticulitis</description>
        <time_frame>2 years</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Observational</title>
          <description>The observation group will be followed clinically with no further intervention until the primary endpoint is reached.</description>
        </group>
        <group group_id="E2">
          <title>Surgery</title>
          <description>The surgery group will be offered colon resection.
Colon resection: Elective robotic/laparoscopic/open colon resection for diverticular disease.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Partial small bowel obstruction due to ileus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Surgical site infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Roberto Bergamaschi, MD, PhD</name_or_title>
      <organization>Stony Brook Medicine</organization>
      <phone>631-638-2215</phone>
      <email>roberto.bergamaschi@stonybrookmedicine.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

